Description

  • The consortium consists of proprietary & generic pharmaceutical companies & suppliers to improve the quality & security of their supply chains. Recent publicized events have highlighted a weakness in the supply chain. Examples include: Adulterated glycerin used to manufacture cough syrup & teething gel has led to 67 deaths in Panama, 103 deaths in Haiti and 40 infant deaths in Nigeria & adulterated heparin led to 81 deaths in the US & Europe. The globalization of distribution for both drug components & finished products has introduced many complications that are unresolved. Unethical players & noncompliant companies along the supply chain can introduce counterfeited & adulterated materials, often with tragic consequences. Such incidents lead to a loud & swift reaction from the public, health authorities & policy makers. Legislatures, Regulators & Organizations around the world are attempting to develop local solutions to this complex & global problem, which can be best addressed with a single global response that a consortium can deliver. The consortium will have four distinct functions: 1) Standard Setting: the consortium will scan external sources for the best available standards today with the goal for consortium members to adopt best practices with a sense of urgency. 2) Data Sharing: The consortium will act as a clearing house for vital supply chain information. Consortium members will report suspicious & pertinent events to the consortium, which will disseminate the information, evaluate the impact & then develop potential proactive solutions for its members to consider adopting. 3) Technology: the consortium will work with world class universities to develop new technologies that will prevent & detect tampering within the supply chain. 4) Audits: the consortium will develop a system that will make audits more thorough & allow firms to share audit findings, & corrective actions making the system more effective & efficient.
  • location

    Headquarters:164 West Main Street Suite C, New Market, Maryland, United States

    More
  • Rx-360 phone

    Phone Number: +1 202-842-8800

  • Rx-360 website

    Website: https://www.rx-360.org

  • Rx-360 employees

    Employees:11

  • Rx-360 revenue

    Revenue:$1 - 10M

  • Rx-360 legal name

    Legal Name:Rx-360

  • Rx-360's Social Media

    Rx-360 linkedin Rx-360 facebook Rx-360 twitter
  • done Is this data correct?
  • |  NAICS Code: 813319  |

    Show More
Person level website identification

CEO for Rx-360

James Fries

Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Jaye Greene

Head Of Audit Operations And Quality

Michael Cavacini

Head Of Membership Development And Marketing

Brittany Tobery

Project Manager

Brian Shipley

Manager, Licensing Program

Hannah Song

Quality Assurance Manager

Frequently Asked Questions regarding Rx-360

  • Where are Rx-360's Headquarters?

    Rx-360's Headquarters are in 164 West Main Street Suite C,New Market,Maryland,United States

  • What is Rx-360's phone number?

    Rx-360's phone number is +1 202-842-8800

  • What is Rx-360's official website?

    Rx-360's official website is https://www.rx-360.org

  • What is Rx-360's Revenue?

    Rx-360's revenue is $1 - 10M

  • What is Rx-360's NAICS code?

    Rx-360's NAICS code is 813319

  • How many employees are working in Rx-360

    Rx-360 has 11 employees

  • What is Rx-360's Industry?

    Rx-360 is in the industry of Pharmaceuticals

  • Who is Rx-360's CEO?

    Rx-360's CEO is James Fries

Company Directory